Browse by Last Name
Jill Bates , Pharm.D., MS, BCOP
Jill S. Bates, MS, Pharm. D, BCOP, is a clinical pharmacist practitioner practicing in lymphoma and myeloma clinics within the University of North Carolina (UNC) Medical Center; an Assistant Professor of Clinical Education at the UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina. She received her Doctor of Pharmacy degree at the University of Illinois at Chicago and a research-based Master of Science in Biochemistry and Biophysics from Northern Illinois University. Jill completed an ASHP-accredited pharmacy practice (PGY1) and oncology (PGY2) residency at Duke University Medical Center. Jill is Board-certified in Oncology Pharmacy.
Prior to entering the profession of pharmacy, Jill was a high school science teacher. As part of her professional service, Jill has been an active member of ASHP as well as HOPA. Jill's involvement with ASHP has included serving on the Council on Therapeutics as Vice Chair and Chair. Further, she served on the New Practitioner Education Advisory Group and as a member of the Educational Steering Committee, Clinical Leadership Section Advisory Group and the Preceptor Skills and Development Section Advisory Group for the Section of Clinical Specialists and Scientists. In 2012, Jill was elected Chair of the Section of Clinical Scientists and Specialists. As part of her professional service, Jill is an active manuscript reviewer for various pharmacy journals.
Sara K. Butler, Pharm.D., BCPS, BCOP
Lung Cancer; Adult Sarcoma
Sara Butler is a Clinical Pharmacy Specialist currently working for Barnes-Jewish Hospital on the inpatient medical oncology service. She is a graduate of the University of North Carolina at Chapel Hill School of Pharmacy and completed both a Pharmacy Practice and Oncology Pharmacy Residency at Duke University Hospital in Durham, NC. At Barnes-Jewish Hospital, she serves as the Oncology Clinical Pharmacist Supervisor and the Residency Program Director for the Oncology Pharmacy Residency Program in addition to her clinical responsibilities.
Courtney Cavalieri , Pharm.D., BCOP
Lower Gastrointestinal and Pancreatic Cancers
Karen M. Fancher , Pharm.D., BCOP
Chronic Leukemias; Lymphomas
Karen Fancher, Pharm.D., BCOP, is an Assistant Professor of Pharmacy Practice in Oncology Acute Care at Duquesne University Mylan School of Pharmacy. She is a graduate of Duquesne University and completed a Pharmacy Practice Residency at Thomas Jefferson University Hospital in Philadelphia, followed by a Specialty Residency in Oncology Pharmacy Practice at the H. Lee Moffitt Cancer Center & Research Institute in Tampa. She then spent almost 10 years as a Clinical Pharmacist in the Blood & Marrow Transplant Division at the H. Lee Moffitt Cancer Center before returning to Pittsburgh to work with the West Penn Allegheny Oncology Network. Dr. Fancher’s current practice site is the University of Pittsburgh Medical Center at Passavant Hospital. She has had several roles within the Hematology Oncology Pharmacy Association, routinely lectures at both the collegiate and national levels, and has been nominated for ASHP’s Preceptor of the Year Award. Dr. Fancher’s research interests include chronic leukemias, hematopoietic stem cell transplantation and the management of chronic iron overload.
Christopher A. Fausel , Pharm.D., MHA, BCOP
Oncology Practice Management
Christopher Fausel, Pharm.D. M.H.A., BCOP is the Clinical Manager, Oncology Pharmacy at the Indiana University Simon Cancer Center (IUSCC) in Indianapolis, Indiana. He graduated from Albany College of Pharmacy with a BS Pharmacy in 1993 and Pharm.D. in 1996 and completed residency training at the Stratton VA Medical Center in Albany, NY. He oversees the clinical and dispensing pharmacy services at the IUSCC ambulatory infusion center and five satellite infusion clinics. In addition, he is the Chairman of the Board of the Hoosier Oncology Group, a non-profit organization that conducts clinical trials and translational research in cancer and serves as the administrative center of the Big Ten Cancer Research Consortium. He holds academic appointments to the Department of Medicine at the Indiana University School of Medicine, Purdue University School of Pharmacy and Pharmaceutical Sciences, and Butler University College of Pharmacy. He is the founding Residency Program Director for the PGY2 Oncology Pharmacy Residency at Indiana University Health. He serves on the Indiana University Purdue University at Indianapolis IRB and the Indiana University Simon Cancer Center Scientific Review Committee. He is a long-standing member of ASHP, ASCO and HOPA.
Monique D. Giordana, Pharm.D., BCOP
Gynecologic Malignancies; Multiple Myeloma
Dr. Monique Giordana, Pharm.D., BCOP is a Hematology/Oncology Clinical Pharmacy Specialist practicing at Regions Hospital in both the inpatient & outpatient settings. Additionally she serves as an oncology pharmacy specialist resource for HealthPartners outreach oncology sites and clinics. Dr. Giordana is also a founding board member of the Upper Midwest Oncology Education Network.
Monique received her Doctor of Pharmacy from the University Of Minnesota College Of Pharmacy in 2008. She went on to complete a pharmacy practice residency at the Dallas VA Medical center and a hematology/oncology specialty residency at Mayo Clinic in Rochester, Minnesota.
Lauren Ice, Pharm.D.
Hematopoietic Stem Cell Transplantation
Lauren Ice graduated with her PharmD from Ohio Northern University and completed her PGY1 Residency and PGY2 Oncology Residency at Mayo Clinic in Rochester, Minnesota. Since completion of residency, she has worked as a clinical pharmacist specializing in hematopoietic stem cell transplant at Spectrum Health in Grand Rapids, Michigan, where she is actively involved in patient care, research, and education. Dr. Ice is a board certified pharmacist in pharmacotherapy and oncology.
Michelle L. Kussin, Pharm.D., BCOP
Michelle Kussin is a Pediatric Oncology Clinical Pharmacy Specialist at Memorial Sloan Kettering Cancer Center, in NY, NY, where she has worked since 2013. She completed her Doctor of Pharmacy education at the South Carolina College of Pharmacy - Columbia Campus. She went on to a PGY-1 pharmacy practice residency at Boston Medical Center in Boston, MA, followed by a PGY-2 residency in pediatric oncology at Memorial Sloan Kettering Cancer Center in New York City. She is a Board Certified Oncology Pharmacist (BCOP) and member of the American College of Clinical Pharmacy (ACCP), American Society for Blood and Marrow Transplantation (ASBMT), and Children’s Oncology Group (COG) organizations. In her current position, Michelle rotates in leukemia/lymphoma and bone marrow transplant services in both the in-patient and out-patient settings, and serves as a preceptor for the PGY-2 pediatric oncology residency.
Andrea Landgraf Oholendt, Pharm.D., BCOP
Upper Gastrointestinal and Hepatocellular Carcinomas
Andrea Landgraf Oholendt, Pharm.D., BCOP is Clinical Pharmacy Specialist in the Division of Pharmacy at The University of Texas MD Anderson Cancer Center in Houston, Texas. Her primary responsibilities include collaborating with the Gastrointestinal Medical Oncology multidisciplinary team in the care of patients with gastrointestinal (GI) cancers. In addition to her patient care responsibilities, Dr. Landgraf serves as the program director for the Post Graduate Year 2 Oncology Pharmacy Residency program at MD Anderson. She has presented nationally on topics related to GI cancers and is actively involved in research. Dr. Landgraf received her Doctor of Pharmacy degree from The University of Arizona in Tucson, Arizona. She completed a Pharmacy Practice Residency at The Methodist Hospital in Houston, Texas and an Oncology Pharmacy Practice Residency at The University of Texas MD Anderson Cancer Center. Dr. Landgraf became a Board Certified Oncology Pharmacist in 2006 and is a member of several organizations, including ASHP, ACCP, ASCO, and HOPA.
Steven Ludlow, Pharm.D., BCOP, BCPS
Prostate Cancer; Bladder, Renal, and Testicular Cancers
Elyse MacDonald, PharmD, BCPS
Research Design, Statistics, and Evaluating Oncology Literature
Dr. Elyse MacDonald joined the University of Utah Drug Information Service (DIS) in July 2012. In her current role, she helps to manage ongoing drug shortages, supports the pharmacy and therapeutics committee and formulary management, incorporates medication safety improvements, and precepts students and residents. Prior to joining the DIS, she was an advanced clinical pharmacy specialist in drug information and medication safety at Intermountain Medical Center (IMC) located in Murray, UT. At IMC, she also coordinated and developed the investigational drug service for the hospital. Elyse earned a Bachelor of Science degree in Biochemistry from Cedar Crest College located in Allentown, PA. She earned her Master of Science degree in Pharmaceutical Chemistry from Lehigh University located in Bethlehem, PA. Prior to pharmacy school, Elyse worked as an analytical chemistry and then as a clinical supplies project leader for GlaxoSmithKline. She earned received her Pharm.D. in 2008 from Creighton University School of Pharmacy and Health Professions in Omaha, NE. She completed her Pharmacy Practice Residency at the Philadelphia VA Medical Center in June 2009 and completed a Drug Information specialty residency at the University of Utah Hospitals and Clinics in June 2010. Elyse’s current pharmacy interests focus on drug information practice, drug policy, medication safety, and research pharmacy.
Anthony Perisonetti, Pharm.D., BCOP
Cancer-Releated Infectious Diseases
Danielle L. Roman, Pharm.D., BCOP
Dr. Danielle Roman is the manager for oncology clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, Pennsylvania. Her practice is focused on the provision on cancer care for a large ambulatory community practice. In her current position, she is responsible for optimization of chemotherapy regimens based on patient specific comorbidities, development of evidence-based chemotherapy order templates, and management of supportive care issues for patients receiving anticancer agents. Her focus is on the pharmacological management of solid tumors and toxicity associated with cancer treatment. Dr. Roman is also responsible for the education of patients and caregivers receiving intravenous and oral anticancer agents. Dr. Roman has served as adjunct clinical faculty for Duquesne University School of Pharmacy and has lectured at the University Of Pittsburgh School Of Pharmacy for the past six years. She is a preceptor for community practice and oncology pharmacy residents, as well as pharmacy students.
Dr. Roman received her doctorate of pharmacy from the Duquesne University Mylan School of Pharmacy and completed her post-graduation residency training at The Johns Hopkins Hospital where she specialized in oncology pharmacy.
Her research and scholarly activities focus on supportive care for individuals with cancer and multiple comorbidities and management of oral chemotherapy.
Dr. Roman is an active member the board of directors for the Greater Pittsburgh American Cancer Society.
Christine M. Walko, Pharm.D., BCOP
Melanoma and Non-Melanoma Skin Cancer; Head, Neck and CNS Malignancies
Christine M. Walko, Pharm.D., FCCP, BCOP, graduated with her Doctor of Pharmacy degree from Duquesne University in Pittsburgh, Pennsylvania and completed a Pharmacy Practice Residency at the Medical College of Virginia/VCU in Richmond, Virginia, and a Hematology/Oncology Specialty residency at the University of North Carolina (UNC). She stayed at UNC to complete a two year academic oncology fellowship focused on drug metabolism and translational research before taking an assistant professor position at UNC in the Division of Pharmacotherapy and Experimental Therapeutics. Christine is now an Applied Clinical Scientist in the Division of Population Science and Clinical Pharmacogenetics Scientist at the Personalized Medicine Institute at Moffitt Cancer Center. Her research focus is on optimizing drug therapy by using pharmacogenomics and pharmacokinetics to personalize intravenous and oral anticancer therapy for cancer patients. Additionally, she is an attending for the Personalized Medicine Consult Service and Chair of the Clinical Genomics Action Committee (CGAC), Moffitt's Molecular Tumor Board. The purpose of the consult service and CGAC is to aid in the rational implementation of cancer genomics (and other individualized treatment approaches), by providing multidisciplinary assessment of advanced diagnostic strategies and complex clinical results. Ultimately, this committee translates genetic results into recommendations for individual patient treatments and these formal consults are documented in the patient’s medical record.